CASC
Cascadian Therapeutics Inc
Cascadian Therapeutics Inc 13F Holders
CASC Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $4.31
1 value investing guru has made changes to the Cascadian Therapeutics Inc (CASC) position according to the gurus' 2016 Q4 SEC quarterly report(s). The number of CASC shares has been decreased by 1 super investor(s).
Which gurus or hedge funds bought CASC in 2016 Q4?
According to the 2016 Q4 SEC filing(s) Cascadian Therapeutics Inc (CASC) has not been purchased by any super investor.
To see more about who is investing in Cascadian Therapeutics Inc (CASC), please go to the CASC ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.